FEDERAL COURT OF AUSTRALIA
Les Laboratoires Servier v Apotex Pty Ltd [2009] FCA 1139
Apotex Pty Ltd v Les Laboratoires Servier (No 2) [2009] FCA 1019 related
LES LABORATOIRES SERVIER v APOTEX PTY LTD (ACN 096 916 148); LES LABORATOIRES SERVIER and SERVIER LABORATORIES (AUST) PTY LTD (ACN 004 838 500) v APOTEX PTY LTD (ACN 096 916 148), SYMBION PHARMACY SERVICES PTY LTD (ACN 000 875 034), CHEM MART PTY LIMITED (ACN 001 235 374), PHARMACOR LIMITED (ACN 121 020 835), GENEPHARM (AUSTRALIA) LIMITED (ARBN 003 854 626) and SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)
NSD 1036 of 2009
FOSTER J
6 OCTOBER 2009
SYDNEY
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 1036 of 2009
BETWEEN: LES LABORATOIRES SERVIER
ApplicantAND: APOTEX PTY LTD (ACN 096 916 148)
RespondentAND BETWEEN: LES LABORATOIRES SERVIER
First Cross-ClaimantSERVIER LABORATORIES (AUST) PTY LTD (ACN 004 838 500)
Second Cross-ClaimantAND: APOTEX PTY LTD (ACN 096 916 148)
First Cross-RespondentSYMBION PHARMACY SERVICES PTY LTD (ACN 000 875 034)
Second Cross-RespondentCHEM MART PTY LIMITED (ACN 001 235 374)
Third Cross-RespondentPHARMACOR LIMITED (ACN 121 020 835)
Fourth Cross-RespondentGENEPHARM (AUSTRALIA) LIMITED (ARBN 003 854 626)
Fifth Cross-RespondentSIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)
Sixth Cross-Respondent
JUDGE:
FOSTER J
DATE OF ORDER:
6 OCTOBER 2009
WHERE MADE:
SYDNEY
THE COURT ORDERS THAT:
1.The application for leave to appeal filed by the respondent below on 18 September 2009 be heard concurrently with, or immediately before, the hearing of the appeal and any matters arising out of any Notice of Contention served by the respondent to the appeal.
2.The respondent file and serve any Notice of Contention by 9 October 2009.
3.The application for leave to appeal and the consequent appeal be included in the list of cases to be called over in the next available Full Court sittings.
4.The costs of the application for leave to appeal so far be reserved for disposition by the Full Court.
Note:Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.
The text of entered orders can be located using eSearch on the Court’s website.
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 1036 of 2009
BETWEEN: LES LABORATOIRES SERVIER
ApplicantAND: APOTEX PTY LTD (ACN 096 916 148)
RespondentAND BETWEEN: LES LABORATOIRES SERVIER
First Cross-ClaimantSERVIER LABORATORIES (AUST) PTY LTD (ACN 004 838 500)
Second Cross-ClaimantAND: APOTEX PTY LTD (ACN 096 916 148)
First Cross-RespondentSYMBION PHARMACY SERVICES PTY LTD (ACN 000 875 034)
Second Cross-RespondentCHEM MART PTY LIMITED (ACN 001 235 374)
Third Cross-RespondentPHARMACOR LIMITED (ACN 121 020 835)
Fourth Cross-RespondentGENEPHARM (AUSTRALIA) LIMITED (ARBN 003 854 626)
Fifth Cross-RespondentSIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)
Sixth Cross-Respondent
JUDGE:
FOSTER J
DATE:
6 OCTOBER 2009
PLACE:
SYDNEY
REASONS FOR JUDGMENT
This is an application for leave to appeal from a decision of a…
Keep reading for free
Create a free CaseChat account to read Les Laboratoires Servier v Apotex Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2009] FCA 1139
- Decision Date
CaseChat Overview and Summary
The court examined the evidence and arguments presented by both parties regarding the patent's validity and infringement. It scrutinised the claims of the patent, the prior art, and the specific technical features of the invention. The court found that the patent was valid and had indeed been infringed by Apotex. The court ruled that Servier had not anticipated its own invention through prior disclosures. The reasoning focused on the technical specifications of the patent and the differences between the alleged prior art and the patented invention.
The outcome of the case was that the appeal filed by Apotex was dismissed. The court found no merit in Apotex's arguments regarding the patent's validity and infringement. The application for leave to appeal was denied, and the costs of the application were reserved for disposition by the Full Court. The court ordered that the application for leave to appeal and the consequent appeal be included in the list of cases to be called over in the next available Full Court sittings, and that any Notice of Contention be filed and served by 9 October 2009.
Orders
Orders of the court
1. The application for leave to appeal filed by the respondent below on 18 September 2009 be heard concurrently with, or immediately before, the hearing of the appeal and any matters arising out of any Notice of Contention served by the respondent to the appeal.
2. The respondent file and serve any Notice of Contention by 9 October 2009.
3. The application for leave to appeal and the consequent appeal be included in the list of cases to be called over in the next available Full Court sittings.
4. The costs of the application for leave to appeal so far be reserved for disposition by the Full Court.
Note:
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Established by: FOSTER J
Full text does not contain this section.